Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00541164 · ClinicalTrials.gov registry record · Phase 1
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
A Phase 1 study, sponsored by Memorial Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00541164: Completed Phase 1 study, sponsored by Memorial Medical Center.
NCT00541164 is a Phase 1 study that has completed, run by Memorial Medical Center. The registered enrollment target is 23 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00541164, a Phase 1 study, has completed, sponsored by Memorial Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The object of this research is to test the effectiveness of Coenzyme Q10 (CoQ10) on symptoms of weakness, fatigue, and pain in persons with Charcot-Marie-Tooth disease (CMT).In this study we also intend to examine the impact of daily supplementation on overall quality of life.We are also interested in identifying any differences in serum ratios of CoQ10 in the oxidized and reduced forms.
Interventions
- DIETARY_SUPPLEMENT Coenzyme Q10
- DRUG Coenzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
What the finished NCT00541164 record still lists
NCT00541164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which Coenzyme Q10 is the first listed.
NCT00541164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00541164 about?
NCT00541164 is a clinical study titled "Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease". The object of this research is to test the effectiveness of Coenzyme Q10 (CoQ10) on symptoms of weakness, fatigue, and pain in persons with Charcot-Marie-Tooth disease (CMT).In this study we also intend to examine the impact of daily supplementation on overall quality of life.We are also interested ...
What is the current status of trial NCT00541164?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2007-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00541164?
The interventions under investigation include: Coenzyme Q10 (DIETARY_SUPPLEMENT), Coenzyme Q10 (DRUG).
Who is sponsoring clinical trial NCT00541164?
This trial is sponsored by Memorial Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00541164's enrollment target sits among peer trials
23 1596th of 2000 higher than 400 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia